GI Adenocarcinoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal Cancer (NCT02291614) | Amgen | 2014-11-27 |
Track GI Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.